Skip to content
Review Open access

Immunological Mechanisms of the Gut-brain-cardiovascular Axis in Coronary Heart Disease with Comorbid Anxiety and Depression.

Aug 2026 · Iranian Journal of Allergy, Asthma and Immunology · Vol 25 5, pp. 623-631 · 0 citations
Medicine

TL;DR

A narrative review systematically summarizes recent advances in the immunological mechanisms underlying CHD complicated by anxiety and depression, focusing on gut microbiota-immune interactions, inflammatory signaling pathways, immune-related microbial metabolites, and neuroimmune communication that collectively shape cardiovascular and mental health.

Abstract

Coronary heart disease (CHD) is frequently accompanied by anxiety and depression, conditions that markedly worsen cardiovascular outcomes. Increasing evidence indicates that immune dysregulation, driven by gut microbiota alterations, plays a central role in linking psychological disorders with cardiovascular pathology through the gut-brain-cardiovascular axis. This narrative review systematically summarizes recent advances in the immunological mechanisms underlying CHD complicated by anxiety and depression. We focus on gut microbiota-immune interactions, inflammatory signaling pathways, immune-related microbial metabolites, and neuroimmune communication that collectively shape cardiovascular and mental health. Relevant studies addressing immune biomarkers, cytokine profiles, intestinal barrier dysfunction, and immune-modulating therapeutic strategies were critically analyzed. Gut microbiota dysbiosis contributes to intestinal barrier impairment and translocation of microbial products, leading to activation of innate and adaptive immune responses. Elevated pro-inflammatory cytokines, including interleukin 6 and tumor necrosis factor α, serve as key mediators linking systemic inflammation with atherosclerosis and neuropsychiatric symptoms. Microbial metabolites, such as trimethylamine N-oxide, exacerbate immune-driven vascular inflammation, whereas short-chain fatty acids exert immunoregulatory and anti-inflammatory effects. Neuroimmune mechanisms, including hypothalamic-pituitary-adrenal (HPA) axis activation and immune modulation of autonomic function, further integrate psychological stress with cardiovascular immune injury. Immune dysregulation represents a unifying mechanism connecting gut microbiota imbalance, neuropsychiatric disorders, and coronary heart disease. Targeting immune-microbiota interactions within the gut-brain-cardiovascular axis may offer novel diagnostic biomarkers and immunomodulatory therapeutic strategies for CHD patients with comorbid anxiety and depression. This immunological perspective provides a translational framework for future research and integrated clinical management.

Read PDF

Similar papers

Review Open access Sep 2026

THE GUT-BRAIN AXIS: EXPLORING THE IMPACT OF GUT MICROBIOTA ON MENTAL HEALTH

Current knowledge on the mechanisms by which gut microbiota may influence mental health and microbiota-targeted therapeutic approaches are summarized to clarify causal mechanisms, identify effective microbial interventions, and determine their place in mental health prevention and treatment are summarized.

Agnieszka Kafara, Zuzanna Kafara, Julia Koronczok-Matusiak et al. · 0 citations
Review Open access Aug 2026

Immuno-Metabolic Interactions Along the Microbiota-Gut-Brain Axis in Ischemic Stroke: A Narrative Review.

BACKGROUND AND PURPOSE Ischemic stroke (IS) remains a leading global cause of mortality and disability. Although current reperfusion strategies have advanced, the complex pathological mechanisms underlying IS continue to significantly limit clinical prognosis. Recently, the pivotal role of the microbiota-gut-brain axis...

Zhengyuan Liu, Xin-Wei Zhao, Ze-Yu Yang et al. · 0 citations
Review Open access Aug 2026

Bridging the gut and mind: a narrative review of depression in Crohn’s disease and emerging gut-brain axis therapies

It is suggested that therapeutic responses in Crohn’s disease-associated depression may depend on the extent to which interventions modulate distinct components of the GBA, including immune, neural, and microbial pathways.

Zoë Pipa, Newton Howard · 0 citations
Review Aug 2026

Gut Microbiota-Derived Metabolites in Cardiovascular and Neuropsychiatric Comorbidity: From Mechanistic Insights to Therapeutic Frontiers.

This review critically reviewed microbiome-targeted interventions and found that although the existing literature provides reliable epidemiological associations and proof of concept in animal models, definitive causal relationships in human populations remain insufficiently confirmed.

Yu-Shen Guan, Jia-Hao Duan, Chun Yang et al. · 0 citations
Review Open access Sep 2026

Gut-Brain Axis-mediated Neurological Manifestations in Inflammatory Bowel Disease: Mechanisms and Disease Spectrum.

Inflammatory bowel disease (IBD) is a chronic immune-mediated disorder of the gastrointestinal tract that is frequently associated with neuropsychiatric comorbidities, such as anxiety, depression, and other neurological disorders. Accumulating evidence suggests that these neuropsychiatric disorders are secondary condit...

Bing-Chan Sun, Guo-Xin Wang, Xiao-Xiao Li et al. · 0 citations
Review Open access Sep 2026

GUT MICROBIOTA AND THE GUT–BRAIN AXIS IN ANXIETY DISORDERS: CURRENT EVIDENCE AND THERAPEUTIC PERSPECTIVES

Current evidence indicates that gut microorganisms moderate central nervous system functioning through neural, immunological, endocrine, and metabolic pathways, and available evidence indicates that gut microorganisms moderate central nervous system functioning through neural, immunological, endocrine, and metabolic pa...

Monika Sas-Wyżykowska, Anna Wyżykowska, M. Maruszak et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.